Ocular antibiotic arsenal continues to expand

Hasson, Matt
September 2009
Primary Care Optometry News;Sep2009, Vol. 14 Issue 9, p16
The article focuses on a presentation by optometrist Blair Lonsberry at Optometry's Meeting in Washington which noted the importance for optometrists to be knowledgeable on various antibiotics for treating ocular infections.


Related Articles

  • Combination Drugs.  // Review of Optometry;6/15/2010 Suppl, p26A 

    The article offers information on the significance of combination drugs in treating acute red eye in the U.S. It states that combination drug is best suited if a significant epithelial compromise exists. It notes that combination drugs are essential in addressing conjunctival inflammation, while...

  • Combination Drugs.  // Review of Optometry;5/15/2011 Supplement, p29A 

    The article focuses on the factors that medical personnel need to consider in the selection of topical antibiotic drug, whether a pure steroid or a combination drug, in the treatment of eye inflammation such as red eye. It notes that most red eye cases are treated with a combination drug. It...

  • Corticosteroids.  // Review of Optometry;5/15/2012 Clinical Guide to Ophtha, p16A 

    The article discusses the treatment of red eyes with the combination of antibiotic-steroid. It indicates that the use of potent steroid will suppress the leukocytic infiltrate, and thus heal the overlying epithelial defect of an inflamed eye. It also provides a detailed understanding on the...

  • The Other Side of Antibiotics. Abelson, Mark B.; Shapiro, Aron; Makino, Akimitsu; Lane, Keith // Review of Ophthalmology;Jun2008 Part 1 of 2, Vol. 15 Issue 6, p70 

    The article explores on the anti-inflammatory capability of antibiotics. It cites several studies which examined the anti-inflammatory capabilities of several antibiotics, including fluoroquinolones, tetracyclines, erythromycin and azithromycin. Moreover, it discusses the clinical relevance of...

  • Cool approach to managing hot lids. Patel, Amit // Optometry Today;2/8/2013, Vol. 53 Issue 3, p47 

    The article offers tips on treating lid margin disease. Symptoms of blepharitis include redness, itching, crusting and fluctuating vision. Conducting a careful and thorough history taking is recommended to help evaluate the severity of the disease and its impact on daily life. Primary care...

  • Eye care: infection or allergy? Farrer, Fae // South African Pharmacist's Assistant;Spring2012, Vol. 12 Issue 3, p29 

    The article focuses on several types of conjunctivitis and its treatment. It says allergies or infections are the usual cause of the condition, characterized by red eyes. It cites various types of the disease including viral, bacterial and allergic conjunctivitis. It mentions some treatment...

  • When Blepharoconjunctivitis Refuses to Go Away. Bethke, Walter // Review of Ophthalmology;Oct2008, Vol. 15 Issue 10, p64 

    The article offers tips for diagnosing the cause of the inflamed eye and treating it successfully. Clinicians stress that history and physical exam can help categorize the blepharoconjunctivitis which makes it easier in treating. Ophthalmologists recommend to tailor the treatment such as using...

  • Role of Inflammation in Endophthalmitis. Vallejo-Garcia, J. L.; Asencio-Duran, M.; Pastora-Salvador, N.; Vinciguerra, P.; Romano, M. R. // Mediators of Inflammation;2012, Vol. 2012, p1 

    Inflammation originating from infection of the vitreous cavity is called endophthalmitis. Attention has been focused on the epidemiologic, microbiologic reports, and treatment options; unfortunately, the role of the host immune reaction in the visual function damage is still not well understood....

  • The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis. Malhotra, Ranjan; Ackerman, Stacey; Gearinger, Lynne S.; Morris, Timothy W.; Allaire, Catherine // Drugs in R&D;Dec2013, Vol. 13 Issue 4, p243 

    Background: Besifloxacin ophthalmic suspension 0.6 % (Besivance ®; Bausch & Lomb, Rochester, NY, USA) was approved by the FDA in 2009 for the treatment of bacterial conjunctivitis, with a recommended 7-day dosing regimen. Objective: The objective of this study was to compare the safety of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics